Şuayib Yalçın

Suayib Yalcin during a press conference }}

Suayib Yalcin MD (Turkish: Şuayib Yalçın) is a medical oncologist. He has authored/co-authored more than 80 articles. Provided by Wikipedia
Showing 1 - 7 results of 7 for search 'Suayib Yalcin', query time: 0.05s Refine Results
  1. 1
    A Narrative Review of RAS Mutations in Early-Stage Colorectal Cancer: Mechanisms and Clinical Implications

    A Narrative Review of RAS Mutations in Early-Stage Colorectal Cancer: Mechanisms and Clinical Implications by Hasan Cagri Yildirim, Damla Gunenc, Elvina Almuradova, Osman Sutcuoglu, Suayib Yalcin

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    RAS Mutations in Advanced Colorectal Cancer: Mechanisms, Clinical Implications, and Novel Therapeutic Approaches

    RAS Mutations in Advanced Colorectal Cancer: Mechanisms, Clinical Implications, and Novel Therapeutic Approaches by Osman Sütcüoğlu, Hasan Çağrı Yıldırım, Elvina Almuradova, Damla Günenç, Şuayib Yalçın

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Expert opinion on the current conceptual, clinical and therapeutic aspects of disease related malnutrition and muscle loss: a multidisciplinary perspective

    Expert opinion on the current conceptual, clinical and therapeutic aspects of disease related malnutrition and muscle loss: a multidisciplinary perspective by Mutlu Doganay, Meltem Gulhan Halil, Cetin Kaymak, Ugur Selek, Mehmet Akif Topcuoglu, Suayib Yalcin

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    THSD7A as a novel prognostic factor for colorectal carcinoma

    THSD7A as a novel prognostic factor for colorectal carcinoma by Oktay Halit Aktepe, Olcay Kurtulan, Pinar Ezgi Dama, Ahmet Melih Arslan, Elif Atag, Meral Uner, Berfu Korucu, Aziz Karaoglu, Suayib Yalcin

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Total cholesterol/high-density lipoprotein cholesterol ratio is a candidate predictor of survival outcomes in patients with metastatic renal cell carcinoma

    Total cholesterol/high-density lipoprotein cholesterol ratio is a candidate predictor of survival outcomes in patients with metastatic renal cell carcinoma by Oktay Halit Aktepe, Ozge Yetginoglu, Mehmet Sinan Akarca, Canberk Sencan, Ahmet Unal, Elif Atag, Huseyin Salih Semiz, Aziz Karaoglu, Mustafa Erman, Suayib Yalcin

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Adjuvant Gemcitabine-cisplatin Combination for Biliary Tract Cancer: A Real Life Experience

    Adjuvant Gemcitabine-cisplatin Combination for Biliary Tract Cancer: A Real Life Experience by Fatih Kuş, Hasan Çağrı Yıldırım, Arif Akyıldız, Ömer Denizhan Tatar, Alperen Özmen, Fırat Şirvan, Fatih Boynueğrioğlu, Barış Köksal, Deniz Can Güven, Ömer Dizdar, Şuayib Yalçın

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Prognostic and predictive value of systemic inflammatory markers in patients with metastatic gastric and GEJ adenocarcinoma with PD-L1 CPS score ≥ 5: Turkish Oncology Group (TOG) study

    Prognostic and predictive value of systemic inflammatory markers in patients with metastatic gastric and GEJ adenocarcinoma with PD-L1 CPS score ≥ 5: Turkish Oncology Group (TOG) s... by Maral Martin Mildanoglu, Yasin Kutlu, Onur Bas, Bahadır Koylu, Shute Ailia Dae, Abdullah Sakin, Dilek Erdem, Mehmet Ali Nahit Sendur, Elif Senocak Tasci, Faysal Dane, Ali Osman Kaya, Musa Baris Aykan, Yakup Ergun, Sedat Biter, Omer Dizdar, Umut Disel, Fatih Selcukbiricik, Fatih Kose, Omer Fatih Olmez, Gokhan Demir, Suayib Yalcin, Ahmet Bilici

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: